Bayview Pharmacy's Chlorpheniramine Maleate 12 mg Slow Release Capsules are a meticulously compounded formulation designed to provide effective relief from a variety of allergic conditions. This formulation is specifically engineered to gradually release the active ingredient, chlorpheniramine maleate, over an extended period of time, ensuring a sustained therapeutic effect.

These capsules are formulated with Methocel E4M, a type of controlled-release polymer. This innovative technology allows for the encapsulated medication to be released gradually, offering a prolonged therapeutic effect. This slow release mechanism reduces the need for frequent dosing and improves patient compliance, particularly beneficial for medications requiring a controlled and extended release profile.

Chlorpheniramine Maleate 12 mg Slow Release Capsules are indicated for the treatment of allergic rhinitis, urticaria, and other allergic conditions. They are also effective in managing symptoms of the common cold, such as sneezing, runny nose, and itching. The encapsulated form of these capsules makes them easy to take and store, while the slow release of the active ingredient ensures better symptom control over a longer period of time.

At Bayview Pharmacy, we are dedicated to providing our customers with high-quality care and effective compounding solutions. If you have any questions about this formulation or any other compounding services we offer, we encourage you to reach out to us. We are here to assist you with your healthcare needs.

Chlorpheniramine Maleate 12 mg Slow Release Capsules are a compounded formulation designed for the treatment of various allergic reactions such as allergic rhinitis, urticaria, and other hypersensitivity responses. This formulation is also effective in managing symptoms associated with the common cold, including sneezing, runny nose, and itching. The capsules are formulated with Methocel E4M, a type of controlled-release polymer, which ensures the gradual release of the active ingredient over an extended period. This slow-release mechanism offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for medications requiring a controlled and prolonged release profile.

It is important for patients to be aware that Chlorpheniramine Maleate 12 mg Slow Release Capsules may interact with other medications. These include anticholinergics, antihistamines, and monoamine oxidase inhibitors (MAOIs). Therefore, patients should inform their healthcare provider of all medications they are currently taking before starting this treatment. Potential side effects of Chlorpheniramine Maleate 12 mg Slow Release Capsules include drowsiness, dry mouth, and dizziness. As such, patients are advised not to drive or operate machinery until they understand how this medication affects them. For any questions or concerns regarding the use of Chlorpheniramine Maleate 12 mg Slow Release Capsules, patients are encouraged to reach out to their healthcare provider.

Chlorpheniramine Maleate 12 mg Slow Release Capsules are a potent formulation designed to alleviate symptoms associated with allergies, hay fever, and the common cold. The active ingredient, chlorpheniramine maleate, is a powerful antihistamine that functions by inhibiting the action of histamine, a substance in the body that triggers allergic symptoms. The unique slow-release formulation of these capsules, made possible by the use of Methocel E4M, a controlled-release polymer, ensures a gradual and consistent release of the medication over an extended period. This slow-release mechanism offers sustained therapeutic effects, thereby reducing the frequency of dosing and enhancing patient compliance, particularly for medications that necessitate a controlled and prolonged release profile.

The recommended dosage for adults and children over 12 years of age is one capsule every 12 hours. For children under 12 years of age, the appropriate dosage should be determined by a healthcare provider. It's important to note that common side effects of this medication may include drowsiness, dry mouth, and dizziness. If any of these side effects are experienced, it is advised to contact a healthcare provider immediately. For any further queries or concerns regarding Chlorpheniramine Maleate 12 mg Slow Release Capsules, please do not hesitate to reach out.

Chlorpheniramine Maleate 12 mg Slow Release Capsules are a versatile medication, formulated with Methocel E4M, a controlled-release polymer. This design allows for the gradual release of the active ingredient over an extended period, providing sustained therapeutic effects, reduced dosing frequency, and improved patient compliance. This medication is primarily used for the treatment of various allergic conditions such as allergic conjunctivitis, reactions to insect bites, and food allergies. It is also effective in managing symptoms of the common cold, including sneezing, runny nose, and itchy eyes.

Additionally, Chlorpheniramine Maleate 12 mg Slow Release Capsules can be used to alleviate nausea and vomiting caused by motion sickness. Beyond these uses, this medication has shown efficacy in treating symptoms of Parkinson’s disease, such as tremors, muscle stiffness, and difficulty walking. It can also be beneficial in managing symptoms of anxiety, including restlessness, irritability, and difficulty sleeping. If you have any questions about the use of Chlorpheniramine Maleate 12 mg Slow Release Capsules for any of these conditions, please do not hesitate to reach out for further information.